Trial Profile
An observational cohort study in renal cell carcinoma and soft tissue sarcoma patients to identify the number of patients at risk of suboptimal treatment due to low exposure.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 Jan 2018
Price :
$35
*
At a glance
- Drugs Pazopanib (Primary)
- Indications Leiomyosarcoma; Nerve sheath neoplasms; Renal cell carcinoma; Soft tissue sarcoma; Synovial sarcoma
- Focus Pharmacokinetics; Therapeutic Use
- 02 Jan 2018 New trial record
- 01 Dec 2017 Results of exposure response analysis published in the Cancer Chemotherapy and Pharmacology